-
Company Insights
Innovation and Patenting activity of Medpace Holdings Inc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Medpace Holdings Inc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ventilator Associated Pneumonia (VAP) Clinical Trials Market Report Overview The Ventilator Associated Pneumonia (VAP) clinical trial market research report provides an overview of Ventilator Associated Pneumonia Clinical trials scenario. This report provides top-line data relating to the clinical trials on Ventilator Associated Pneumonia. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Clinical Trials – Precision and Personalized Medicine
This report provides analysis of clinical research involving precision and personalized medicines and identifies trends throughout the years. The terms precision and personalized medicine are often used interchangeably as they refer to similar types of treatment. They both define the stratification of patients within a disease segment using their genomic and phenotypic variations to find targeted therapies. This is an alternative to the traditional process of drug design, which typically follows a one-size-fits all approach. Precision and personalized medicine is...
-
Product Insights
Medpace – Cincinnati Mixed-Use Development – Ohio
Equip yourself with the essential tools needed to make informed and profitable decisions with our Medpace - Cincinnati Mixed-Use Development - Ohio report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the Medpace...
-
Company Profile
Medpace Holdings Inc – Company Profile
Medpace Holdings Inc (Medpace) is a clinical research organization that provides outsourced clinical development services. It provides full-service Phase I to Phase IV clinical trial services, project management, regulatory affairs, data management, clinical monitoring, and post-market clinical support. The company also provides clinical human pharmacology, bio-analytical laboratory services, electrocardiography reading support, and various imaging services. Medpace carries out clinical trials of products for various conditions in cardiology, metabolic disease, endocrinology, central nervous system (CNS), oncology, and antiviral and anti-infective (AVAI)....
Add to Basket -
Product Insights
Tinnitus – Global Clinical Trials Review, H2, 2021
GlobalData's clinical trial report, “Tinnitus - Global Clinical Trials Review, H2, 2021" provides an overview of Tinnitus Clinical trials scenario. This report provides top line data relating to the clinical trials on Tinnitus . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs...